WES analysis of TCS627 did indicate a mutation in WNT7A, a factor that can activate the canonical and non-canonical Wnt pathways described as a tumor suppressor in lung cancer but also as an oncogene in ovarian, breast and brain tumors [51,52]. Here, WNT7A is linked to neoplasm.